PSP Pharma (შპს პსპ ფარმა) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

PSP Pharma (შპს პსპ ფარმა) — Georgia Financials

separate · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	477,265	490,933	541,555	634,296	745,080	744,758	775,596	845,163	+8.5%
Total COGS	353,369	371,016	386,288	465,255	580,879	578,158	591,126	655,105	+9.2%
Gross Profit	123,896	119,917	155,267	169,041	164,201	166,600	184,470	190,058	+6.3%
Gross Margin	26.0%	24.4%	28.7%	26.7%	22.0%	22.4%	23.8%	22.5%
Other Operating Income	3,813	4,741	0	0	0	0	0	0	+24.3%
	86,115	93,339	96,199	100,586	93,067	111,080	126,633	132,946	+6.4%
EBITDA	41,594	31,319	59,068	68,455	71,134	55,520	57,837	57,112	+4.6%
EBITDA Margin	8.7%	6.4%	10.9%	10.8%	9.5%	7.5%	7.5%	6.8%
Total D&A	7,354	6,743	20,369	22,686	19,339	23,899	22,004	20,234	+15.6%
	0	0	36	0	0	913	0	0	+193.8%
EBIT / Operating Income	34,240	24,576	38,663	45,769	51,795	30,708	35,833	36,878	+1.1%
Total Interest Income	346	767	207	286	9,881	19,089	4,267	6,310	+51.4%
Total Interest Expense	230	249	13,710	22,271	9,463	9,957	9,508	12,159	+76.3%
	1,259	203	685	4,983	10,597	13,835	7,849	79	nmf
Profit Before Tax	33,097	25,297	25,845	18,801	62,810	53,675	38,441	31,108	-0.9%
Total Income Tax	0	0	0	0	0	0	0	0
Net Profit / (Loss)	33,097	25,297	24,954	16,613	61,813	51,406	35,964	28,984	-1.9%
Net Margin	6.9%	5.2%	4.6%	2.6%	8.3%	6.9%	4.6%	3.4%